Biogen Stocks Fall As They Tweak Their Research

 

The Biotechnology company Biogen is changing plans for their study on Alzheimer’s based on mid-study findings, making investors less confident. Based on their findings, 510 patients will need to be added to the final stage of the study. Biogen CMO Al Sandrock said, “ We did do a preplanned blinded sample size re-estimation. We did see more variability in the primary endpoint than assumed when we did the original sample size estimation, so we decided to increase the sample size to maintain 90% power. Therefore, we’re going to add 510 patients to the two studies.” With the recent changes and growing concerns for their stockholders, hopefully Biogens study will still pay off.

Follow us on social media for the latest updates in B2B!

Image

Latest

continuous improvement in education
Continuous Improvement in Education: If You Want Different Outcomes, Change the System
February 24, 2026

School systems across the country are under mounting pressure to improve student outcomes while navigating shifting standards, staffing shortages, and rising expectations around accountability. Yet many reform efforts fall short because they are fragmented and short-term. According to Learning Forward’s Standards for Professional Learning, sustained and job-embedded professional learning is linked to improved educator…

Read More
growing with sales
Get Vertical! Growing with Sales for Success
February 24, 2026

Buying behavior has shifted dramatically. Today’s B2B customers do most of their research before ever speaking with a salesperson. In fact, 61% of B2B buyers say they prefer a rep-free buying experience, according to a 2025 Gartner survey. At the same time, U.S. retail e-commerce sales exceeded $1.192 trillion in 2024. Growth still depends…

Read More
All Blacks
Standards, Identity, and Legacy: Leadership Lessons from the All Blacks and Other Elite Teams with James Kerr
February 23, 2026

Dynasties are rare. Most teams rise, win for a season, and fade. A superstar retires. A coach leaves. The chemistry shifts. What once felt inevitable suddenly looks fragile. Sustained excellence is far harder than a single championship run — it requires standards that survive ego, systems that outlast individuals, and a culture strong enough to…

Read More
governance
Exploring the Intersection of Board Governance, Community Engagement and Creativity with Ann Margolin
February 23, 2026

Behind every city vote, hospital budget or zoning decision is a leader navigating tough, often conflicting priorities. Right now, public leaders are operating in an environment of rising healthcare costs, workforce shortages and heightened community expectations—especially within safety-net systems that collectively provide billions in uncompensated care each year. The stakes are real—they affect patients…

Read More